Total Payments
$1,870
2024 Payments
$39.76
Companies
8
Transactions
37
Medicare Patients
1,743
Medicare Billing
$237,876
Payment Breakdown by Category
Food & Beverage$1,870 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,870 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Piramal Critical Care | $1,173 | 5 | $0 (2018) |
| Allergan Inc. | $254.20 | 11 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $221.55 | 10 | $0 (2019) |
| Ipsen Biopharmaceuticals, Inc | $82.42 | 3 | $0 (2024) |
| Saol Therapeutics Inc. | $55.86 | 4 | $0 (2018) |
| BOSTON SCIENTIFIC CORPORATION | $47.15 | 1 | $0 (2021) |
| Purdue Pharma L.P. | $25.38 | 2 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $10.48 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39.76 | 1 | Ipsen Biopharmaceuticals, Inc ($39.76) |
| 2023 | $24.37 | 1 | Ipsen Biopharmaceuticals, Inc ($24.37) |
| 2021 | $47.15 | 1 | BOSTON SCIENTIFIC CORPORATION ($47.15) |
| 2019 | $138.78 | 3 | Avanir Pharmaceuticals, Inc. ($90.00) |
| 2018 | $1,354 | 14 | Piramal Critical Care ($1,173) |
| 2017 | $265.78 | 17 | Avanir Pharmaceuticals, Inc. ($115.13) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/16/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $39.76 | General |
| Category: Neurology | ||||||
| 05/09/2023 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Neurology | ||||||
| 10/14/2021 | BOSTON SCIENTIFIC CORPORATION | EXALT (Device) | Food and Beverage | Cash or cash equivalent | $47.15 | General |
| Category: EXALT | ||||||
| 09/24/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 06/01/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: NEUROSCIENCE | ||||||
| 06/01/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2018 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $65.56 | General |
| 06/14/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/13/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 06/05/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/11/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: HYPERHYDROSIS | ||||||
| 04/25/2018 | Saol Therapeutics Inc. | Lioresal Intrathecal (baclofen injection) (Drug), Dysport | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: Severe Spasticity | ||||||
| 04/19/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: HYPERHYDROSIS | ||||||
| 04/11/2018 | Purdue Pharma L.P. | SYMPROIC (Drug) | Food and Beverage | Cash or cash equivalent | $11.76 | General |
| Category: CONSTIPATION | ||||||
| 03/20/2018 | Piramal Critical Care | GABLOFEN 1 mL in 1 SYRINGE, GLASS (Drug) | Food and Beverage | In-kind items and services | $234.63 | General |
| Category: Pharmacology | ||||||
| 03/20/2018 | Piramal Critical Care | GABLOFEN 1 mL in 1 SYRINGE, GLASS (Drug) | Food and Beverage | In-kind items and services | $234.63 | General |
| Category: Pharmacology | ||||||
| 03/20/2018 | Piramal Critical Care | GABLOFEN 1 mL in 1 SYRINGE, GLASS (Drug) | Food and Beverage | In-kind items and services | $234.63 | General |
| Category: Pharmacology | ||||||
| 03/20/2018 | Piramal Critical Care | GABLOFEN 1 mL in 1 SYRINGE, GLASS (Drug) | Food and Beverage | In-kind items and services | $234.63 | General |
| Category: Pharmacology | ||||||
| 03/20/2018 | Piramal Critical Care | GABLOFEN 1 mL in 1 SYRINGE, GLASS (Drug) | Food and Beverage | In-kind items and services | $234.63 | General |
| Category: Pharmacology | ||||||
| 02/01/2018 | Purdue Pharma L.P. | SYMPROIC (Drug) | Food and Beverage | Cash or cash equivalent | $13.62 | General |
| Category: CONSTIPATION | ||||||
| 12/21/2017 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: HYPERHYDROSIS | ||||||
| 12/12/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 12/07/2017 | Saol Therapeutics Inc. | Lioresal Intrathecal (Drug), Dysport | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Severe Spasticity | ||||||
| 11/02/2017 | Allergan Inc. | BOTOX - SPASTICITY (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: SPASTICITY | ||||||
| 10/25/2017 | Avanir Pharmaceuticals, Inc. | ONZETRA Xsail (Drug) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: Migraine | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 387 | 711 | $139,066 | $52,133 |
| 2022 | 6 | 542 | 930 | $183,500 | $67,860 |
| 2021 | 6 | 382 | 718 | $170,067 | $51,966 |
| 2020 | 6 | 432 | 905 | $130,789 | $65,917 |
Total Patients
1,743
Total Services
3,264
Medicare Billing
$237,876
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 179 | 485 | $74,205 | $30,680 | 41.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 93 | 99 | $28,710 | $10,123 | 35.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 46 | 46 | $19,550 | $6,341 | 32.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 41 | 41 | $6,273 | $2,624 | 41.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 16 | $5,120 | $1,210 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 24 | $5,208 | $1,156 | 22.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 218 | 582 | $86,136 | $33,299 | 38.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 206 | 216 | $60,696 | $23,207 | 38.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 38 | 40 | $16,480 | $6,126 | 37.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 35 | 36 | $5,328 | $2,096 | 39.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 23 | 31 | $9,610 | $2,033 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 22 | 25 | $5,250 | $1,098 | 20.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 139 | 464 | $81,396 | $27,074 | 33.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 115 | 116 | $44,938 | $11,995 | 26.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 41 | 42 | $21,315 | $6,928 | 32.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 42 | 42 | $7,948 | $2,490 | 31.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 29 | 33 | $7,485 | $1,740 | 23.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 16 | 21 | $6,985 | $1,738 | 24.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 154 | 608 | $68,704 | $36,338 | 52.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 120 | 121 | $25,773 | $13,557 | 52.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 56 | 58 | $17,226 | $9,597 | 55.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 62 | 64 | $9,600 | $3,818 | 39.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 19 | 26 | $5,244 | $1,424 | 27.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 21 | 28 | $4,242 | $1,183 | 27.9% |
About Dr. Riley Smith, M.D
Dr. Riley Smith, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Dearborn, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2011. The National Provider Identifier (NPI) number assigned to this provider is 1285923649.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Riley Smith, M.D has received a total of $1,870 in payments from pharmaceutical and medical device companies, with $39.76 received in 2024. These payments were reported across 37 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,870).
As a Medicare-enrolled provider, Smith has provided services to 1,743 Medicare beneficiaries, totaling 3,264 services with total Medicare billing of $237,876. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Dearborn, MI
- Active Since 04/06/2011
- Last Updated 10/22/2020
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1285923649
Products in Payments
- GABLOFEN 1 mL in 1 SYRINGE, GLASS (Drug) $1,173
- NUEDEXTA (Drug) $182.04
- BOTOX THERAPEUTIC (Biological) $82.97
- BOTOX (Biological) $82.52
- Dysport (Drug) $64.13
- BOTOX (Drug) $48.78
- EXALT (Device) $47.15
- Lioresal Intrathecal (Drug) $44.99
- ONZETRA Xsail (Drug) $39.51
- SYMPROIC (Drug) $25.38
- BOTOX - SPASTICITY (Drug) $20.12
- BOTOX NEURO REHAB (Drug) $19.81
- Dysport 300 U-1 (Drug) $18.29
- Lioresal Intrathecal (baclofen injection) (Drug) $10.87
- SYNVISC-ONE (Device) $10.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Dearborn
In Yoon, Md, MD
Physical Medicine & Rehabilitation — Payments: $22,463
Physical Medicine & Rehabilitation $22,463
Eduardo Otero-Loperena, Md, MD
Physical Medicine & Rehabilitation — Payments: $6,822
Physical Medicine & Rehabilitation $6,822
Luis Torregrosa, Md, MD
Physical Medicine & Rehabilitation — Payments: $5,037
Physical Medicine & Rehabilitation $5,037
Dr. Johnathan Ho, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $2,826
Physical Medicine & Rehabilitation $2,826
Yongmin Liu
Physical Medicine & Rehabilitation — Payments: $1,233
Physical Medicine & Rehabilitation $1,233
Dr. Sungho Hong, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,007
Physical Medicine & Rehabilitation $1,007